APA (7th ed.) Citation

Stahler, A., Karthaus, M., Fruehauf, S., Graeven, U., Müller, L., Weikersthal, L. F. v., . . . Modest, D. P. Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): Final efficacy analysis of a randomised, open-label, phase 2 trialResearch in context. Elsevier.

Chicago Style (17th ed.) Citation

Stahler, Arndt, et al. Panitumumab Plus 5-fluorouracil and Folinic Acid or 5-fluorouracil and Folinic Acid Alone as Maintenance Therapy In RAS Wild-type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212): Final Efficacy Analysis of a Randomised, Open-label, Phase 2 TrialResearch in Context. Elsevier.

MLA (9th ed.) Citation

Stahler, Arndt, et al. Panitumumab Plus 5-fluorouracil and Folinic Acid or 5-fluorouracil and Folinic Acid Alone as Maintenance Therapy In RAS Wild-type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212): Final Efficacy Analysis of a Randomised, Open-label, Phase 2 TrialResearch in Context. Elsevier.